Lyme disease diagnostic devices are used to detect disease which is caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular,
This report contains market size and forecasts of Lyme Disease Diagnostic Devices in global, including the following market information:
Global Lyme Disease Diagnostic Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lyme Disease Diagnostic Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Lyme Disease Diagnostic Devices companies in 2021 (%)
The global Lyme Disease Diagnostic Devices market was valued at 946.5 million in 2021 and is projected to reach US$ 1531.8 million by 2028, at a CAGR of 7.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serological Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lyme Disease Diagnostic Devices include Abbott Laboratories, T2 Biosystems, Inc., Bio-Rad Laboratories, Alere Inc., Roche Diagnostics, Covance Inc., Immunetics, Inc., GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) and Oxford Immunotec Global PLC(Boulder Diagnostics Inc.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lyme Disease Diagnostic Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lyme Disease Diagnostic Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lyme Disease Diagnostic Devices Market Segment Percentages, by Type, 2021 (%)
Serological Test
Urine Antigen Tests
Lymphocytic Transformation Test
Immunofluorescent Staining
Nucleic Acid Test
Global Lyme Disease Diagnostic Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lyme Disease Diagnostic Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Public/Private Laboratories
Physician’s Office
Global Lyme Disease Diagnostic Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lyme Disease Diagnostic Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lyme Disease Diagnostic Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lyme Disease Diagnostic Devices revenues share in global market, 2021 (%)
Key companies Lyme Disease Diagnostic Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Lyme Disease Diagnostic Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
T2 Biosystems, Inc.
Bio-Rad Laboratories
Alere Inc.
Roche Diagnostics
Covance Inc.
Immunetics, Inc.
GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
Thermo Fisher Scientific(Affymetrix)
Siemens AG
Baxter International Inc.
Fresenius Medical Care AG & Co.